Atlas Trials

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

Clinical trial NCT01007864 · COMPLETED

Trial details

NCT number
NCT01007864
Sponsor
Desitin Arzneimittel GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Parkinson's Disease
Start date
2010-01-01
Primary completion
2011-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.